Filament Health EBITDA vs. Current Valuation

FLHLF Stock  USD 0.04  0  3.15%   
Considering the key profitability indicators obtained from Filament Health's historical financial statements, Filament Health Corp may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Filament Health's ability to earn profits and add value for shareholders.
For Filament Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Filament Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Filament Health Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Filament Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Filament Health Corp over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Filament Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Filament Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Filament Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Filament Health Corp Current Valuation vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Filament Health's current stock value. Our valuation model uses many indicators to compare Filament Health value to that of its competitors to determine the firm's financial worth.
Filament Health Corp is rated below average in ebitda category among its peers. It is rated below average in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Filament Health's earnings, one of the primary drivers of an investment's value.

Filament Current Valuation vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Filament Health

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(9.08 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Filament Health

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
7.57 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Filament Current Valuation vs Competition

Filament Health Corp is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 4.72 Billion. Filament Health adds roughly 7.57 Million in current valuation claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.

Filament Health Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Filament Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Filament Health will eventually generate negative long term returns. The profitability progress is the general direction of Filament Health's change in net profit over the period of time. It can combine multiple indicators of Filament Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants conducts genetic research performs extraction procedures runs in-house trials and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. Filament Health is traded on OTC Exchange in the United States.

Filament Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Filament Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Filament Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Filament Health's important profitability drivers and their relationship over time.

Use Filament Health in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Filament Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Filament Health will appreciate offsetting losses from the drop in the long position's value.

Filament Health Pair Trading

Filament Health Corp Pair Trading Analysis

The ability to find closely correlated positions to Filament Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Filament Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Filament Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Filament Health Corp to buy it.
The correlation of Filament Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Filament Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Filament Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Filament Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Filament Health position

In addition to having Filament Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aluminum Thematic Idea Now

Aluminum
Aluminum Theme
Companies involved in production of aluminum. The Aluminum theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aluminum Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Filament OTC Stock

To fully project Filament Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Filament Health Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Filament Health's income statement, its balance sheet, and the statement of cash flows.
Potential Filament Health investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Filament Health investors may work on each financial statement separately, they are all related. The changes in Filament Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Filament Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.